← All trials

NCT03068819

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Oct 23, 2017
Primary completion
Oct 20, 2026
Completion date
Oct 20, 2026
First posted
Mar 3, 2017
Last posted
Oct 31, 2022
Enrollment
110
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.